Home/Filings/4/0001493152-21-019829
4//SEC Filing

Orzechowski Frank 4

Accession 0001493152-21-019829

CIK 0000788611other

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 7:00 PM ET

Size

8.2 KB

Accession

0001493152-21-019829

Insider Transaction Report

Form 4
Period: 2021-08-11
Orzechowski Frank
CFO, PFO and PAO
Transactions
  • Award

    Stock Option (right to buy)

    2021-08-11+48,58048,580 total
    Exercise: $3.42Exp: 2026-08-11Common Stock (48,580 underlying)
  • Award

    Stock Appreciation Right

    2021-08-11+48,58048,580 total
    Exercise: $3.42Exp: 2026-08-11Common Stock (48,580 underlying)
Footnotes (2)
  • [F1]The stock option will vest and become exercisable as follows: (i) 25% of the option vested on the grant date (i.e., August 11, 2021), and (ii) the balance of the option will vest in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.
  • [F2]The stock appreciation right ("SAR") is payable in cash only, and vests as follows: (i) 25% of the SAR vested on the grant date (i.e., August 11, 2021), and (ii) the balance of the SAR will vest in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.

Documents

1 file

Issuer

SIGMA LABS, INC.

CIK 0000788611

Entity typeother

Related Parties

1
  • filerCIK 0001781860

Filing Metadata

Form type
4
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 7:00 PM ET
Size
8.2 KB